CRISPR Therapeutics (NASDAQ:CRSP) reported $300.00 thousand in sales this quarter. This is a 102.70 percent increase over sales of $148.00 thousand the same period last year.
Benzinga2021-11-04
CRISPR Therapeutics (NASDAQ:CRSP) reported $300.00 thousand in sales this quarter. This is a 102.70 percent increase over sales of $148.00 thousand the same period last year.
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。